Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

IDEXX LABORATORIES INC /DE Director's Dealing 2010

Feb 17, 2010

30016_dirs_2010-02-17_49075c4a-71f7-4b4e-8357-36f9145203d4.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: IDEXX LABORATORIES INC /DE (IDXX)
CIK: 0000874716
Period of Report: 2010-02-14

Reporting Person: MURRAY ROBERT J (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2010-02-14 Common Stock M 1309 Acquired 35398 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2010-02-14 Non-Qualified Stock Option (right to buy) $53.3100 A 5962 Acquired 2017-02-13 Common Stock (4962) Direct
2010-02-14 Restricted Stock Unit $ A 516 Acquired Common Stock (516) Direct
2010-02-14 Restricted Stock Unit $ M 1309 Disposed Common Stock (1309) Direct

Footnotes

F1: Grant of option to buy shares of IDEXX Laboratories, Inc. common stock becomes exercisable on 2/14/2011.

F2: Each restricted stock unit represents a contingent right to receive one share of IDEXX Laboratories, Inc. common stock. Restricted stock units vest 100% one year from the date of grant.